|
|
Volumn 6, Issue 5, 2009, Pages 334-336
|
|
Antiplatelet therapy: Personalized medicine for clopidogrel resistance?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
BIOLOGICAL MARKER;
CLOPIDOGREL;
DRUG DERIVATIVE;
TICLOPIDINE;
BLOOD;
BLOOD CLOTTING PARAMETERS;
DRUG RESISTANCE;
HUMAN;
NOTE;
PATIENT SELECTION;
PREDICTION AND FORECASTING;
RISK ASSESSMENT;
TREATMENT FAILURE;
BIOLOGICAL MARKERS;
DRUG RESISTANCE;
HUMANS;
PATIENT SELECTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET FUNCTION TESTS;
PREDICTIVE VALUE OF TESTS;
RISK ASSESSMENT;
TICLOPIDINE;
TREATMENT FAILURE;
|
|
EID: 67649550607
PISSN: None
EISSN: 17595010
Source Type: Journal
DOI: 10.1038/nrcardio.2009.28 Document Type: Note |
|
Times cited : (19)
|
|
References (0)
|
